top of page
Who we are
Novocuff, Inc. is a medical device company dedicated to improving pregnancy outcomes and reducing preterm births caused by PPROM and cervical shortening.
Why it matters
Preterm birth is the leading cause of death for infants under the age of one. According to the World Health Organization (WHO), preterm birth complications were responsible for approximately 1 million deaths in 2020.
Novocuff has developed a groundbreaking medical device to address the complex problems associated with the preterm birth conditions of PPROM and short cervix. The Novocuff Cervical Control System (CCS) has been designed with the goal of stabilizing and closing the cervix to retain amniotic fluid and sustain cervical length, with the aim of extending pregnancy.
CAUTION - Investigational device. Limited by United States law to investigational use.
Team
Amelia Degenkolb
CEO
Donald Lee
COO
Kathryn Wine
VP of Clinical Affairs
Marissa VanDeVeer
Clinical Engineer
Cindy Domecus
Regulatory Affairs
team
news
bottom of page